The Drug-Induced Respiratory Disease Website

I - Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)

I.j

Asystole

1

Evidence level

low

X - Pulmonary edema

X.b

Pulmonary edema, noncardiogenic (NCPE)

1

Evidence level

low

XIII - Thrombosis - Embolism

XIII.a

Pulmonary embolism - Venous thrombosis/thrombo-embolism

1

Evidence level

low

XIII.f

Fat/oil embolism - The FES embolism syndrome

2

Evidence level

possible

XIV - Pleural involvement

XIV.a

Pleural effusion (uni or bilateral) (can accompany ILD induced by the drug)

1

Evidence level

low

XIV.f

Pneumothorax

1

Evidence level

low

XXII - Acute respiratory/cardiorespiratory failure

XXII.b

Acute lung injury - ARDS

1

Evidence level

low

XXXIII - Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)

XXXIII.o

Path: Lipid/fat embolism

2

Evidence level

possible

XXXVIII - Miscellaneous - Varia

XXXVIII.h

Hypoxemia, low oxygen saturation (may occur in isolation)

1

Evidence level

low